Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Induction and Maintenance in Pediatric UC
NCT02277223Phase 3Withdrawn
- Sponsor
- Schneider Children's Medical Center of Israel
- Start
- Mar 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Schneider Children's Medical Center of Israel. Primary endpoint: Pediatric Ulcerative Colitis Activity Index at 6 months. Planned start Mar 2020; status: withdrawn.
Beyond the preview
Go deeper on NCT02277223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02277223.